Vaccination with HPV-18 E7-pulsed dendritic cells in a patient with metastatic cervical cancer
/in Cervical Cancer, Dendritic Cells, International PublicationsOptimizing dendritic cell-based immunotherapy in multiple myeloma
/in Dendritic Cells, International Publications, Multiple MyelomaImmunization against murine multiple myeloma with fusions of dendritic and plasmacytoma cells is potentiated by interleukin 12
/in Dendritic Cells, International Publications, Multiple MyelomaStimulation of autologous antitumor T-cell responses against medullary thyroid carcinoma using tumor lysate-pulsed dendritic cells
/in Dendritic Cells, International Publications, Thyroid CancerIdiotype protein-pulsed dendritic cells produce strong anti-myeloma effects after syngeneic stem cell transplantation in mice
/in Dendritic Cells, International Publications, Multiple MyelomaGeneration of dendritic cells from human bone marrow mononuclear cells: advantages for clinical application in comparison to peripheral blood monocyte derived cells
/in Dendritic Cells, International PublicationsImmunotherapy of solid cancer using dendritic cells pulsed with the HLA-A24-restricted peptide of carcinoembryonic antigen
/in Colorectal Cancer, Dendritic Cells, International PublicationsVaccination with autologous tumour antigen-pulsed dendritic cells in advanced gynaecological malignancies: clinical and immunological evaluation of a phase I trial
/in Dendritic Cells, Endometrial Cancer, International Publications, Ovarian Cancer
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Die IOZK Immuntherapie
Aktuelles und Int. Publikationen
- WT1-mRNA dendritic cell vaccination of patients with glioblastoma multiforme, malignant pleural mesothelioma, metastatic breast cancer, and other solid tumors: type 1 T-lymphocyte responses are associated with clinical outcome
- Autologous tumor lysate-loaded dendritic cell vaccination in glioblastoma patients: a systematic review of literature
- Retrospective Analysis of HLA Class II-Restricted Neoantigen Peptide-Pulsed Dendritic Cell Vaccine for Breast Cancer